← Leaderboards
Anna Upton
Global Alliance For Tb Drug Development
$10,496,979
Attributed
$10,496,979
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.8M · FY2019–23$5M$3.8M$2.5M$1.3M$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$10,496,979 · 1
By mechanism
U19$10,496,979 · 1
Top collaborators
No co-investigators on record.
Most similar at Global Alliance For Tb Drug Development
Same institution · by research overlap
- Nader Fotouhi$4,211,449
- Christopher Blair Cooper$1,061,077
- Khisimuzi E. Mdluli$328,954
- Tian J. Yang$107,215
Others in their field
Other Emerging Leaders on “In Vitro”
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,441,779
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,686,873
- Leonard Freedmand · Leidos Biomedical Research, Inc.$68,796,314
- Timothy Fouts · Advanced Bioscience Laboratories, Inc.$41,541,738
- John Damon Chodera · Sloan-Kettering Inst Can Research$34,949,884
- Tony Moody · Duke University$34,777,314
Research focus
In VitroAbsorptionInvestigational DrugsBiological AvailabilityCellsCollaborationsAntitubercular AgentsCostDesignDrug CandidateDrug DevelopmentDrug DiscoveryDrug IndustryDrug KineticsComputational ChemistryBiochemicalDrug-SensitiveDrug TargetingEvaluationExcretory FunctionFlexibilityHuman ResourcesInnovationIn Vivo
Grant awards (5)
Scientific Core - Compound Optimization and Prioritization.$2,822,282
U19 · FY2023 · AI · contact PI
Scientific Core - Compound Optimization and Prioritization.$850,917
U19 · FY2022 · AI · contact PI
Scientific Core - Compound Optimization and Prioritization.$2,652,211
U19 · FY2021 · AI · contact PI
Scientific Core - Compound Optimization and Prioritization.$2,128,141
U19 · FY2020 · AI · contact PI
Scientific Core - Compound Optimization and Prioritization.$2,043,428
U19 · FY2019 · AI · contact PI